Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance

Abstract Background Understanding mechanisms underlying specific chemotherapeutic responses in subtypes of cancer may improve identification of treatment strategies most likely to benefit particular patients. For example, triple-negative breast cancer (TNBC) patients have variable response to the ch...

Full description

Bibliographic Details
Main Authors: David P. Hill, Akeena Harper, Joan Malcolm, Monica S. McAndrews, Susan M. Mockus, Sara E. Patterson, Timothy Reynolds, Erich J. Baker, Carol J. Bult, Elissa J. Chesler, Judith A. Blake
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
Triple-negative breast cancer
TNBC
Cisplatin
Cisplatin sensitivity
Cancer subtypes
Gene expression
Online Access:http://link.springer.com/article/10.1186/s12885-019-6278-9

Internet

http://link.springer.com/article/10.1186/s12885-019-6278-9

Similar Items